C. S. Yuan u. a.: Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial. In: J Pharmacol Exp Ther. Band 300, Nr. 1, Jan 2002, S. 118–123. PMID 11752106Volltext HTML
E. Freye, L. Latasch: Toleranzentwicklung unter Opioidgabe – Molekulare Mechanismen und klinische Bedeutung. In: Anasthesiol Intensivmed Notfallmed Schmerzther, Band 38, Nr. 1, Jan 2003, S. 14–26. PMID 12522725
L. Shaiova u. a.: A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation. In: Palliat Support Care, Band 5, Nr. 2, Jun 2007, S. 161–166. PMID 17578067
C. S. Yuan u. a.: Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. In: Clin Pharmacol Ther. Band 59, Nr. 4, Apr 1996, S. 469–475. PMID 8612393
C. S. Yuan u. a.: Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial. In: J Pharmacol Exp Ther. Band 300, Nr. 1, Jan 2002, S. 118–123. PMID 11752106Volltext HTML
